Cargando…

Human iPSC-hepatocyte modeling of alpha-1 antitrypsin heterozygosity reveals metabolic dysregulation and cellular heterogeneity

Individuals homozygous for the “Z” mutation in alpha-1 antitrypsin deficiency are known to be at increased risk for liver disease. It has also become clear that some degree of risk is similarly conferred by the heterozygous state. A lack of model systems that recapitulate heterozygosity in human hep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaserman, Joseph E., Werder, Rhiannon B., Wang, Feiya, Matte, Taylor, Higgins, Michelle I., Dodge, Mark, Lindstrom-Vautrin, Jonathan, Bawa, Pushpinder, Hinds, Anne, Bullitt, Esther, Caballero, Ignacio S., Shi, Xu, Gerszten, Robert E., Brunetti-Pierri, Nicola, Liesa, Marc, Villacorta-Martin, Carlos, Hollenberg, Anthony N., Kotton, Darrell N., Wilson, Andrew A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780780/ https://www.ncbi.nlm.nih.gov/pubmed/36476855 http://dx.doi.org/10.1016/j.celrep.2022.111775

Ejemplares similares

Adenine base editing reduces misfolded protein accumulation and toxicity in alpha-1 antitrypsin deficient patient iPSC-hepatocytes
por: Werder, Rhiannon B., et al.
Publicado: (2021)

CRISPR interference interrogation of COPD GWAS genes reveals the functional significance of desmoplakin in iPSC-derived alveolar epithelial cells
por: Werder, Rhiannon B., et al.
Publicado: (2022)

Human iPSC-derived alveolar and airway epithelial cells can be cultured at air-liquid interface and express SARS-CoV-2 host factors
por: Abo, Kristine M., et al.
Publicado: (2020)

Directed differentiation of mouse pluripotent stem cells into functional lung-specific mesenchyme
por: Alber, Andrea B., et al.
Publicado: (2023)

The COPD GWAS gene ADGRG6 instructs function and injury response in human iPSC-derived type II alveolar epithelial cells
por: Werder, Rhiannon B., et al.
Publicado: (2023)

Air-liquid interface culture promotes maturation and allows environmental exposure of pluripotent stem cell–derived alveolar epithelium
por: Abo, Kristine M., et al.
Publicado: (2022)

A Highly Phenotyped Open Access Repository of Alpha-1 Antitrypsin Deficiency Pluripotent Stem Cells
por: Kaserman, Joseph E., et al.
Publicado: (2020)

Human Pluripotent Stem Cell-Derived Intestinal Organoids Model SARS-CoV-2 Infection Revealing a Common Epithelial Inflammatory Response
por: Mithal, Aditya, et al.
Publicado: (2021)

SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response
por: Huang, Jessie, et al.
Publicado: (2020)

De Novo Generation of Pulmonary Ionocytes from Normal and Cystic Fibrosis Human Induced Pluripotent Stem Cells
por: Wang, Ruobing, et al.
Publicado: (2023)

Generation of human alveolar epithelial type I cells from pluripotent stem cells
por: Burgess, Claire L, et al.
Publicado: (2023)

De novo hematopoiesis from the fetal lung
por: Yeung, Anthony K., et al.
Publicado: (2023)

Heterozygosity of the Alpha 1‐Antitrypsin Pi*Z Allele and Risk of Liver Disease
por: Hakim, Aaron, et al.
Publicado: (2021)

Autophagy master regulator TFEB induces clearance of toxic SERPINA1/α-1-antitrypsin polymers
por: Pastore, Nunzia, et al.
Publicado: (2013)

Heterozygosity for the alpha‐1‐antitrypsin Z allele in cirrhosis is associated with more advanced disease
por: Schaefer, Benedikt, et al.
Publicado: (2018)

Ebola virus infection induces a delayed type I IFN response in bystander cells and the shutdown of key liver genes in human iPSC-derived hepatocytes
por: Scoon, Whitney A., et al.
Publicado: (2022)

Culture impact on the transcriptomic programs of primary and iPSC-derived human alveolar type 2 cells
por: Alysandratos, Konstantinos-Dionysios, et al.
Publicado: (2023)

Airway stem cell reconstitution by the transplantation of primary or pluripotent stem cell-derived basal cells
por: Ma, Liang, et al.
Publicado: (2023)

iPSC-Derived Human Hepatocytes as a Novel Model to Investigate Thyroid Hormone Action and Signaling
por: De Oliveira, Lorraine Soares, et al.
Publicado: (2021)

Activation of the c‐Jun N‐terminal kinase pathway aggravates proteotoxicity of hepatic mutant Z alpha1‐antitrypsin
por: Pastore, Nunzia, et al.
Publicado: (2017)

hiPSC hepatocyte model demonstrates the role of unfolded protein response and inflammatory networks in α(1)-antitrypsin deficiency
por: Segeritz, Charis-Patricia, et al.
Publicado: (2018)

Emergence of a Stage-Dependent Human Liver Disease Signature with Directed Differentiation of Alpha-1 Antitrypsin-Deficient iPS Cells
por: Wilson, Andrew A., et al.
Publicado: (2015)

A new method to detect loss of heterozygosity using cohort heterozygosity comparisons
por: Green, Michael R, et al.
Publicado: (2010)

Derivation of Thyroid Follicular Cells From Pluripotent Stem Cells: Insights From Development and Implications for Regenerative Medicine
por: Posabella, Alberto, et al.
Publicado: (2021)

A study of common Mendelian disease carriers across ageing British cohorts: meta-analyses reveal heterozygosity for alpha 1-antitrypsin deficiency increases respiratory capacity and height
por: North, Teri-Louise, et al.
Publicado: (2016)

Multi-modal profiling of human fetal liver hematopoietic stem cells reveals the molecular signature of engraftment
por: Vanuytsel, Kim, et al.
Publicado: (2022)

Assessment of Heterozygosity and Genome-Wide Analysis of Heterozygosity Regions in Two Duroc Pig Populations
por: Ruan, Donglin, et al.
Publicado: (2022)

Generation of a Purified iPSC-Derived Smooth Muscle-like Population for Cell Sheet Engineering
por: Kwong, George, et al.
Publicado: (2019)

Loss of heterozygosity: what is it good for?
por: Ryland, Georgina L., et al.
Publicado: (2015)

Editorial: Progenitors and Stem Cells in Thyroid Development, Disease, and Regeneration
por: Kotton, Darrell N., et al.
Publicado: (2022)

Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
por: Callea, Francesco, et al.
Publicado: (2018)

NBS1 Heterozygosity and Cancer Risk
por: di Masi, Alessandra, et al.
Publicado: (2008)

Loss of Heterozygosity and Its Importance in Evolution
por: Smukowski Heil, Caiti
Publicado: (2023)

Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin
por: Sosulski, Meredith L., et al.
Publicado: (2020)

Alpha-1 Antitrypsin as a Therapeutic Agent for Conditions not Associated with Alpha-1 Antitrypsin Deficiency
por: Wanner, Adam
Publicado: (2015)

Gene therapy for inborn errors of liver metabolism: progress towards clinical applications
por: Brunetti-Pierri, Nicola
Publicado: (2008)

Liver gene therapy: The magic bullet for the sick lung
por: Brunetti-Pierri, Nicola
Publicado: (2022)

Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
por: Petrache, Irina, et al.
Publicado: (2009)

Recombinant Lloviu virus as a tool to study viral replication and host responses
por: Hume, Adam J., et al.
Publicado: (2022)

Correction: Recombinant Lloviu virus as a tool to study viral replication and host responses
por: Hume, Adam J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_co7ojvc42heia03mh97r9dqktq